Литература
1. Abebe W. Effects of taurine on the reactivity of aortas from diabetic rats // Life Sci. - 2008. - Vol. 82. - P. 279-289. [PubMed]
2. Alvarado-Vasquez N., Zamudio P., Ceron E. et al. Effect of glycine in streptozotocin-induced diabetic rats // Comp. Biochem. Physiol. C Toxicol. Pharmacol. - 2003. - Vol. 134. - P. 521-527. [PubMed]
3. Anthrayose C.V., Shashidhar S. Studies on protein and taurine in normal, senile and diabetic cataractous human lenses // Indian J. Physiol. Pharmacol. - 2004. - Vol. 48. - P. 357-360. [PubMed]
4. Arany E., Strutt B., Romanus P. et al. Taurine supplement in early life altered islet morphology, decreased insulitis and delayed the onset of diabetes in non-obese diabetic mice // Diabetologia. - 2004. - Vol. 47. - P. 1831-1837. [PubMed]
5. Askwith T., Zeng W., Eggo M.C., Stevens M.J. Oxidative stress and dysregulation of the taurine transporter in high-glucoseexposed human Schwann cells: implications for pathogenesis of diabetic neuropathy // Am. J. Physiol. Endocrinol. Metab. - 2009. - Vol. 297. - P. E620-E628. [PubMed]
6. Azuma J., Hasegawa H., Sawamura A. et al. Therapy of congestive heart failure with orally administered taurine // Clin. Ther. - 1983. - Vol. 5. - P. 398-408. [PubMed]
7. Azuma J., Sawamura A., Awata N. et al. Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial // Clin. Cardiol. - 1985. - Vol. 8. - P. 276-282. [PubMed]
8. Bellentani S., Pecorari M., Cordoma P. et al. Taurine increases bile acid pool size and reduces bile saturation index in the hamster // J. Lipid Res. - 1987. - Vol. 28. - P. 1021-1027. [PubMed]
9. Brons C., Spohr C., Storgaard H. et al. Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus // Eur. J. Clin. Nutr. - 2004. - Vol. 58. - P. 1239-1247. [PubMed]
10. Casey R.G., Gang C., Joyce M., Bouchier-Hayes D.J. Taurine attenuates acute hyperglycaemia-induced endothelial cell apoptosis, leucocyte-endothelial cell interactions and cardiac dysfunction // J. Vasc. Res. - 2007. - Vol. 44. - P. 31-39. [PubMed]
11. Chang K.J., Kwon W. Immunohistochemical localization of insulin in pancreatic beta-cells of taurine-supplemented or taurine-depleted diabetic rats // Adv. Exp. Med. Biol. - 2000. - Vol. 483. - P. 579-587. [PubMed]
12. Chauncey K.B., Tenner T.E., Jr, Lombardini J.B. et al. The effect of taurine supplementation on patients with type 2 diabetes mellitus // Adv. Exp. Med. Biol. - 2003. - Vol. 526. - P. 91-96. [PubMed]
13. Luca G., Calpona P.R., Caponetti A. et al. Taurine and osmoregulation: platelet taurine content, uptake, and release in type 2 diabetic patients // Metabolism. - 2001. - Vol. 50. - P. 60-64. [PubMed]
14. Di Leo M.A., Santini S.A., Cercone S. et al. Chronic taurine supplementation ameliorates oxidative stress and Na+ K+ ATPase impairment in the retina of diabetic rats // Amino Acids. - 2002. - Vol. 23. - P. 401-406. [PubMed]
15. Di Leo M.A., Ghirlanda G., Gentiloni Silveri N. et al. Potential therapeutic effect of antioxidants in experimental diabetic retina: a comparison between chronic taurine and vitamin E plus selenium supplementations // Free Radic. Res. - 2003. - Vol. 37. - P. 323-330. [PubMed]
16. Di Leo M.A., Santini S.A., Gentiloni Silveri N. et al. Longterm taurine supplementation reduces mortality rate in streptozotocin-induced diabetic rats // Amino Acids. - 2004. - Vol. 27. - P. 187-191. [PubMed]
17. El Mesallamy H.O., El-Demerdash E., Hammad L.N., El Magdoub H.M. Effect of taurine supplementation on hyperhomocysteinemia and markers of oxidative stress in high fructose diet induced insulin resistance // Diabetol. Metab. Syndr. - 2010. - Vol. 2(46). - P. 46. [PMC free article] [PubMed]
18. Elizarova E.P., Nedosugova L.V. First experiments in taurine administration for diabetes mellitus. The effect on erythrocyte membranes // Adv. Exp. Med. Biol. - 1996. - Vol. 403. - P. 583-588. [PubMed]
19. Fennessy F.M., Moneley D.S., Wang J.H. et al. Taurine and vitamin C modify monocyte and endothelial dysfunction in young smokers // Circulation. - 2003. - Vol. 107. - P. 410- 415. [PubMed]
20. Franconi F., Bennardini F., Mattana A. et al. Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation // Am. J. Clin. Nutr. - 1995. - Vol. 61. - P. 1115-1119. [PubMed]
21. Franconi F., Miceli M., Fazzini A. et al. Taurine and diabetes. Humans and experimental models // Adv. Exp. Med. Biol. - 1996. - Vol. 403. - P. 579-582. [PubMed]
22. Franconi F., Di Leo M.A., Bennardini F., Ghirlanda G. Is taurine beneficial in reducing risk factors for diabetes mellitus? // Neurochem. Res. - 2004. - Vol. 29. - P. 143-150. [PubMed]
23. Franconi F., Loizzo A., Ghirlanda G., Seghieri G. Taurine supplementation and diabetes mellitus // Curr. Opin. Clin. Nutr. Metab. Care. - 2006. - Vol. 9. - P. 32-36. [PubMed]
24. Gandhi V.M., Cherian K.M., Mulky M.J. Hypolipidemic action of taurine in rats // Indian J. Exp. Biol. - 1992. - Vol. 30. - P. 413-417. [PubMed]
25. Gavrovskaya L.K., Ryzhova O.V., Safonova A.F. et al. Protective effect of taurine on rats with experimental insulin-dependent diabetes mellitus // Bull. Exp. Biol. Med. - 2008. - Vol. 146. - P. 226-228. [PubMed]
26. Goodman H.O., Shihabi Z.K. Supplemental taurine in diabetic rats: effects on plasma glucose and triglycerides // Biochem. Med. Metab. Biol. - 1990. - Vol. 43. - P. 1-9. [PubMed]
27. Haber C.A., Lam T.K., Yu Z. et al. N-acetylcysteine (NAC) and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress // Am. J. Physiol. Endocrinol. Metab. - 2003. - Vol. 285. - P. E744-E753. [PubMed]
28. Han J., Bae J.H., Kim S.Y. et al. Taurine increases glucose sensitivity of UCP2-overexpressing beta-cells by ameliorating mitochondrial metabolism // Am. J. Physiol. Endocrinol. Metab. - 2004. - Vol. 287. - P. E1008-E1018. [PubMed]
29. Hansen S.H. The role of taurine in diabetes and the development of diabetic complications // Diabetes Metab. Res. Rev. - 2001. - Vol. 17. - P. 330-346. [PubMed]
30. Hansen S.H., Andersen M.L., Cornett C. et al. A role for taurine in mitochondrial function // J. Biomed. Sci. - 2010. - Vol. 17(Suppl. 1). - P. S23. [PMC free article] [PubMed]
31. Harada N., Ninomiya C., Osako Y. et al. Taurine alters respiratory gas exchange and nutrient metabolism in type 2 diabetic rats // Obes. Res. - 2004. - Vol. 12. - P. 1077-1084. [PubMed]
32. Hayes K.C., Carey R.E., Schmidt S.Y. Retinal degeneration associated with taurine deficiency in the cat // Science. - 1975. - Vol. 188. - P. 949-951. [PubMed]
33. Hayes K.C., Pronczuk A., Addesa A.E., Stephan Z.F. Taurine modulates platelet aggregation in cats and humans // Am. J. Clin. Nutr. - 1989. - Vol. 49. - P. 1211-1216. [PubMed]
34. Higo S., Miyata S., Jiang Q.Y. et al. Taurine administration after appearance of proteinuria retards progression of diabetic nephropathy in rats // Kobe J. Med. Sci. - 2008. - Vol. 54. - P. E35-E45. [PubMed]
35. Huang J.S., Chuang L.Y., Guh J.Y. et al. Antioxidants attenuate high glucose-induced hypertrophic growth in renal tubular epithelial cells // Am. J. Physiol. Renal Physiol. - 2007. - Vol. 293. - P. F1072-F1082. [PubMed]
36. Huang J.S., Chuang L.Y., Guh J.Y. et al. Effect of taurine on advanced glycation end products-induced hypertrophy in renal tubular epithelial cells // Toxicol. Appl. Pharmacol. - 2008. - Vol. 233. - P. 220-226. [PubMed]
37. Huang J.S., Chuang L.Y., Guh J.Y., Huang Y.J. Effects of nitric oxide and antioxidants on advanced glycation end productsinduced hypertrophic growth in human renal tubular cells // Toxicol. Sci. - 2009. - Vol. 111(1). - P. 109-119. [PubMed]
38. Huxtable R.J. Physiological actions of taurine // Physiol. Rev. - 1992. - Vol. 72. - P. 101-163. [PubMed]
39. Huxtable R., Bressler R. Taurine concentrations in congestive heart failure // Science. - 1974. - Vol. 184. - P. 1187-1188. [PubMed]
40. Ito T., Kimura Y., Uozumi Y. et al. Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy // J. Mol. Cell. Cardiol. - 2008. - Vol. 44. - P. 927-937. [PubMed]
41. Kamata K., Sugiura M., Kojima S., Kasuya Y. Restoration of endothelium-dependent relaxation in both hypercholesterolemia and diabetes by chronic taurine // Eur. J. Pharmacol. - 1996. - Vol. 303. - P. 47-53. [PubMed]
42. Kaniuk N.A., Kiraly M., Bates H. et al. Ubiquitinated-protein aggregates form in pancreatic beta-cells during diabetesinduced oxidative stress and are regulated by autophagy // Diabetes. - 2007. - Vol. 56. - P. 930-939. [PubMed]
43. Kirino Y., Yasukawa T., Ohta S. et al. Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease // Proc. Natl Acad. Sci. USA. - 2004. - Vol. 101. - P. 15070-15075. [PMC free article] [PubMed]
44. Kondo Y., Murakami S., Oda H., Nagate T. Taurine reduces atherosclerotic lesion development in apolipoprotein E-deficient mice // Adv. Exp. Med. Biol. - 2000. - Vol. 483. - P. 193-202. [PubMed]
45. Li C., Cao L., Zeng Q. et al. Taurine may prevent diabetic rats from developing cardiomyopathy also by downregulating angiotensin II type2 receptor expression // Cardiovasc. Drugs Ther. - 2005. - Vol. 19. - P. 105-112. [PubMed]
46. Li F., Obrosova I.G., Abatan O. et al. Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats // Am. J. Physiol. Endocrinol. Metab. - 2005. - Vol. 288. - P.E29-E36. [PubMed]
47. Li F., Abatan O.I., Kim H. et al. Taurine reverses neurological and neurovascular deficits in Zucker diabetic fatty rats // Neurobiol. Dis. - 2006. - Vol. 22. - P. 669-676. [PubMed]
48. Malone J.I., Lowitt S., Cook W.R. Nonosmotic diabetic cataracts // Pediatr. Res. - 1990. - Vol. 27. - P. 293-296. [PubMed]
49. Merheb M., Daher R.T., Nasrallah M. et al. Taurine intestinal absorption and renal excretion test in diabetic patients: a pilot study // Diabetes Care. - 2007. - Vol. 30. - P. 2652-2654. [PubMed]
50. Militante J.D., Lombardini J.B., Schaffer S.W. The role of taurine in the pathogenesis of the cardiomyopathy of insulindependent diabetes mellitus // Cardiovasc. Res. - 2000. - Vol. 46. - P. 393-402. [PubMed]
51. Mochizuki H., Takido J., Oda H., Yokogoshi H. Improving effect of dietary taurine on marked hypercholesterolemia induced by a high-cholesterol diet in streptozotocin-induced diabetic rats // Biosci. Biotechnol. Biochem. - 1999. - Vol. 63. - P. 1984-1987. [PubMed]
52. Moloney M.A., Casey R.G., O’Donnell D.H. et al. Two weeks taurine supplementation reverses endothelial dysfunction in young male type 1 diabetics // Diab. Vasc. Dis. Res. - 2010. - Vol. 7. - P. 300-310. [PubMed]
53. Murakami S., Kondo Y., Tomisawa K., Nagate T. Prevention of atherosclerotic lesion development in mice by taurine // Drugs Exp. Clin. Res. - 1999. - Vol. 25. - P. 227-234. [PubMed]
54. Murakami S., Kondo-Ohta Y., Tomisawa K. Improvement in cholesterol metabolism in mice given chronic treatment of taurine and fed a high-fat diet // Life Sci. - 1999. - Vol. 64. - P. 83-91. [PubMed]
55. Murakami S., Kondo Y., Sakurai T. et al. Taurine suppresses development of atherosclerosis in Watanabe heritable hyperlipidemic (WHHL) rabbits // Atherosclerosis. - 2002. - Vol. 163. - P. 79-87. [PubMed]
56. Nakamura T., Ushiyama C., Suzuki S. et al. Effects of taurine and vitamin E on microalbuminuria, plasma metalloproteinase-9, and serum type IV collagen concentrations in patients with diabetic nephropathy // Nephron. - 1999. - Vol. 83. - P. 361- 362. [PubMed]
57. Nakamura-Yamanaka Y., Tsuji K., Ichikawa T. Effect of dietary taurine on cholesterol 7 alpha-hydroxylase activity in the liver of mice fed a lithogenic diet // J. Nutr. Sci. Vitaminol. (Tokyo). - 1987. - Vol. 33. - P. 239-243. [PubMed]
58. Nakaya Y., Minami A., Harada N. et al. Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes // Am. J. Clin. Nutr. - 2000. - Vol. 71. - P. 54-58. [PubMed]
59. Nanami K., Oda H., Yokogoshi H. Antihypercholesterolemic action of taurine on streptozotocin-diabetic rats or on rats fed a high cholesterol diet // Adv. Exp. Med. Biol. - 1996. - Vol. 403. - P. 561-568. [PubMed]
60. Nandhini A.T., Anuradha C.V. Taurine modulates kallikrein activity and glucose metabolism in insulin resistant rats // Amino Acids. - 2002. - Vol. 22. - P. 27-38. [PubMed]
61. Nandhini T.A., Anuradha C.V. Inhibition of lipid peroxidation, protein glycation and elevation of membrane ion pump activity by taurine in RBC exposed to high glucose // Clin. Chim. Acta. - 2003. - Vol. 336. - P. 129-135. [PubMed]
62. Nandhini A.T., Anuradha C.V. Hoe 140 abolishes the blood pressure lowering effect of taurine in high fructose-fed rats // Amino Acids. - 2004. - Vol. 26. - P. 299-303. [PubMed]
63. Nandhini A.T., Thirunavukkarasu V., Anuradha C.V. Stimulation of glucose utilization and inhibition of protein glycation and AGE products by taurine // Acta Physiol. Scand. - 2004. - Vol. 181. - P. 297-303. [PubMed]
64. Nandhini A.T., Thirunavukkarasu V., Ravichandran M.K., Anuradha C.V. Effect of taurine on biomarkers of oxidative stress in tissues of fructose-fed insulin-resistant rats // Singapore Med. J. - 2005. - Vol. 46. - P. 82-87. [PubMed]
65. Obrosova I.G., Stevens M.J. Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens // Invest. Ophthalmol. Vis. Sci. - 1999. - Vol. 40. - P. 680-688. [PubMed]
66. Obrosova I.G., Fathallah L., Stevens M.J. Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy // Exp. Neurol. - 2001. - Vol. 172. - P. 211-219. [PubMed]
67. Obrosova I.G., Minchenko A.G., Marinescu V. et al. Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats // Diabetologia. - 2001. - Vol. 44. - P. 1102-1110. [PubMed]
68. Ogasawara M., Nakamura T., Koyama I. et al. Reactivity of taurine with aldehydes and its physiological role // Chem. Pharm. Bull. (Tokyo). - 1993. - Vol. 41. - P. 2172-2175. [PubMed]
69. Oprescu A.I., Bikopoulos G., Naassan A. et al. Free fatty acidinduced reduction in glucose-stimulated insulin secretion: evidence for a role of oxidative stress in vitro and in vivo // Diabetes. - 2007. - Vol. 56. - P. 2927-2937. [PubMed]
70. Park S.H., Choi H.J., Lee J.H. et al. High glucose inhibits renal proximal tubule cell proliferation and involves PKC, oxidative stress, and TGF-beta 1 // Kidney Int. - 2001. - Vol. 59. - P. 1695-1705. [PubMed]
71. Pennathur S., Heinecke J.W. Oxidative stress and endothelial dysfunction in vascular disease // Curr. Diab. Rep. - 2007. - Vol. 7. - P. 257-264. [PubMed]
72. Pion P.D., Kittleson M.D., Rogers Q.R., Morris J.G. Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy // Science. - 1987. - Vol. 237. - P. 764-768. [PubMed]
73. Pop-Busui R., Sullivan K.A., Huysen C. et al. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits // Exp. Neurol. - 2001. - Vol. 168. - P. 259-272. [PubMed]
74. Satoh H. Cardiac actions of taurine as a modulator of the ion channels // Adv. Exp. Med. Biol. - 1998. - Vol. 442. - P. 121-128. [PubMed]
75. Schaffer S., Takahashi K., Azuma J. Role of osmoregulation in the actions of taurine // Amino Acids. - 2000. - Vol. 19. - P. 527-546. [PubMed]
76. Schaffer S.W., Azuma J., Mozaffari M. Role of antioxidant activity of taurine in diabetes // Can. J. Physiol. Pharmacol. - 2009. - Vol. 87. - P. 91-99. [PubMed]
77. Selvaraj N., Bobby Z., Sathiyapriya V. Effect of lipid peroxides and antioxidants on glycation of hemoglobin: an in vitro study on human erythrocytes // Clin. Chim. Acta. - 2006. - Vol. 366. - P. 190-195. [PubMed]
78. Shao A., Hathcock J.N. Risk assessment for the amino acids taurine, l-glutamine and l-arginine // Regul. Toxicol. Pharmacol. - 2008. - Vol. 50. - P. 376-399. [PubMed]
79. Sjovall J. Dietary glycine and taurine on bile acid conjugation in man; bile acids and steroids 75 // Proc. Soc. Exp. Biol. Med. - 1959. - Vol. 100. - P. 676-678. [PubMed]
80. Son H.Y., Kim H., Y H.K. Taurine prevents oxidative damage of high glucose-induced cataractogenesis in isolated rat lenses // J. Nutr. Sci. Vitaminol. (Tokyo). - 2007. - Vol. 53. - P. 324- 330. [PubMed]
81. Spohr C., Brons C., Winther K. et al. No effect of taurine on platelet aggregation in men with a predisposition to type 2 diabetes mellitus // Platelets. - 2005. - Vol. 16. - P. 301-305. [PubMed]
82. Stevens M.J., Lattimer S.A., Kamijo M. et al. Osmoticallyinduced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat // Diabetologia. - 1993. - Vol. 36. - P. 608-614. [PubMed]
83. Stevens M.J., Hosaka Y., Masterson J.A. et al. Downregulation of the human taurine transporter by glucose in cultured retinal pigment epithelial cells // Am. J. Physiol. - 1999. - Vol. 277. - P. E760-E771. [PubMed]
84. Sturman J.A. Dietary taurine and feline reproduction and development // J. Nutr. - 1991. - Vol. 121. - P. S166-S170. [PubMed]
85. Suzuki T., Suzuki T., Wada T. et al. Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases // EMBO J. - 2002. - Vol. 21. - P. 6581-6589. [PMC free article] [PubMed]
86. Tang C., Han P., Oprescu A.I. et al. Evidence for a role of superoxide generation in glucose-induced beta-cell dysfunction in vivo // Diabetes. - 2007. - Vol. 56. - P. 2722-2731. [PubMed]
87. Tenner T.E., Jr, Zhang X.J., Lombardini J.B. Hypoglycemic effects of taurine in the alloxan-treated rabbit, a model for type 1 diabetes // Adv. Exp. Med. Biol. - 2003. - Vol. 526. - P. 97-104. [PubMed]
88. Tokunaga H., Yoneda Y., Kuriyama K. Protective actions of taurine against streptozotocin-induced hyperglycemia // Biochem. Pharmacol. - 1979. - Vol. 28. - P. 2807-2811. [PubMed]
89. Tokunaga H., Yoneda Y., Kuriyama K. Streptozotocin-induced elevation of pancreatic taurine content and suppressive effect of taurine on insulin secretion // Eur. J. Pharmacol. - 1983. - Vol. 87. - P. 237-243. [PubMed]
90. Trachtman H., Futterweit S., Maesaka J. et al. Taurine ameliorates chronic streptozocin-induced diabetic nephropathy in rats // Am. J. Physiol. - 1995. - Vol. 269. - P. F429-F438. [PubMed]
91. Tsuboyama-Kasaoka N., Shozawa C., Sano K. et al. Taurine (2-aminoethanesulfonic acid) deficiency creates a vicious circle promoting obesity // Endocrinology. - 2006. - Vol. 147. - P. 3276-3284. [PubMed]
92. Ulrich-Merzenich G., Zeitler H., Vetter H., Bhonde R.R. Protective effects of taurine on endothelial cells impaired by high glucose and oxidized low density lipoproteins // Eur. J. Nutr. - 2007. - Vol. 46. - P. 431-438. [PubMed]
93. Vilchis C., Salceda R. Effect of diabetes on levels and uptake of putative amino acid neurotransmitters in rat retina and retinal pigment epithelium // Neurochem. Res. - 1996. - Vol. 21. - P. 1167-1171. [PubMed]
94. Wang L.J., Yu Y.H., Zhang L.G. et al. Taurine rescues vascular endothelial dysfunction in streptozocin-induced diabetic rats: correlated with downregulation of LOX-1 and ICAM-1 expression on aortas // Eur. J. Pharmacol. - 2008. - Vol. 597. - P. 75-80. [PubMed]
95. Winiarska K., Szymanski K., Gorniak P. et al. Hypoglycaemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits // Biochimie. - 2009. - Vol. 91. - P. 261-270. [PubMed]
96. Wu N., Lu Y., He B. et al. Taurine prevents free fatty acid-induced hepatic insulin resistance in association with inhibiting JNK1 activation and improving insulin signaling in vivo // Diabetes Res. Clin. Pract. - 2010. - Vol. 90(3). - P. 288-296. [PubMed]
97. Xiao C., Giacca A., Lewis G.F. Oral taurine but not N-acetylcysteine ameliorates NEFA-induced impairment in insulin sensitivity and beta cell function in obese and overweight, non-diabetic men // Diabetologia. - 2008. - Vol. 51. - P. 139-146. [PubMed]
98. Yamori Y., Liu L., Ikeda K. et al. Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: results from the WHO-CARDIAC study // Hypertens Res. - 2001. - Vol. 24. - P. 453-457. [PubMed]
99. Yao H.T., Lin P., Chang Y.W. et al. Effect of taurine supplementation on cytochrome P450 2E1 and oxidative stress in the liver and kidneys of rats with streptozotocininduced diabetes // Food Chem. Toxicol. - 2009. - Vol. 47. - P. 1703-1709. [PubMed]
100. Yokogoshi H., Mochizuki H., Nanami K. et al. Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a highcholesterol diet // J. Nutr. - 1999. - Vol. 129. - P. 1705- 1712. [PubMed]
101. Yu X., Xu Z., Mi M. et al. Dietary taurine supplementation ameliorates diabetic retinopathy via anti-excitotoxicity of glutamate in streptozotocin-induced Sprague-Dawley rats // Neurochem. Res. - 2008. - Vol. 33. - P. 500-507. [PubMed]
102. Zeng K., Xu H., Mi M. et al. Dietary taurine supplementation prevents glial alterations in retina of diabetic rats // Neurochem. Res. - 2009. - Vol. 34. - P. 244-254. [PubMed]
103. Zeng K., Xu H., Mi M. et al. Effects of taurine on glial cells apoptosis and taurine transporter expression in retina under diabetic conditions // Neurochem. Res. - 2010. - Vol. 35. - P. 1566-1574. [PubMed]
104. Zeng K., Xu H., Chen K. et al. Effects of taurine on glutamate uptake and degradation in Mu .. ller cells under diabetic conditions via antioxidant mechanism // Mol. Cell. Neurosci. - 2010. - Vol. 45. - P. 192-199. [PubMed]
105. Zhang C., Yang J., Jennings L.K. Leukocyte-derived myeloperoxidase amplifies high-glucose-induced endothelial dysfunction through interaction with high-glucose-stimulated, vascular non-leukocyte-derived reactive oxygen species // Diabetes. - 2004. - Vol. 53. - P. 2950-2959. [PubMed]